BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32913122)

  • 1. GGPP depletion initiates metaflammation through disequilibrating CYB5R3-dependent eicosanoid metabolism.
    Wei L; Zheng YY; Sun J; Wang P; Tao T; Li Y; Chen X; Sang Y; Chong D; Zhao W; Zhou Y; Wang Y; Jiang Z; Qiu T; Li CJ; Zhu MS; Zhang X
    J Biol Chem; 2020 Nov; 295(47):15988-16001. PubMed ID: 32913122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
    Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L
    Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UbiA prenyltransferase domain-containing protein-1 modulates HMG-CoA reductase degradation to coordinate synthesis of sterol and nonsterol isoprenoids.
    Schumacher MM; Jun DJ; Johnson BM; DeBose-Boyd RA
    J Biol Chem; 2018 Jan; 293(1):312-323. PubMed ID: 29167270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins inhibit blastocyst formation by preventing geranylgeranylation.
    Alarcon VB; Marikawa Y
    Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of eIF2α attenuates statin-induced apoptosis by inhibiting the stabilization and translocation of p53 to the mitochondria.
    Lee SK; Kim YS
    Int J Oncol; 2013 Mar; 42(3):810-6. PubMed ID: 23354132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of farnesyl pyrophosphate (FPP) and/or geranylgeranyl pyrophosphate (GGPP) biosynthesis and its implication in the treatment of cancers.
    Waller DD; Park J; Tsantrizos YS
    Crit Rev Biochem Mol Biol; 2019 Feb; 54(1):41-60. PubMed ID: 30773935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
    Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
    Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway.
    Woschek M; Kneip N; Jurida K; Marzi I; Relja B
    Nutr Cancer; 2016; 68(3):420-7. PubMed ID: 27042994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geranylgeranyl-regulated transport of the prenyltransferase UBIAD1 between membranes of the ER and Golgi.
    Schumacher MM; Jun DJ; Jo Y; Seemann J; DeBose-Boyd RA
    J Lipid Res; 2016 Jul; 57(7):1286-99. PubMed ID: 27121042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geranylgeranyl pyrophosphate-mediated protein geranylgeranylation regulates endothelial cell proliferation and apoptosis during vasculogenesis in mouse embryo.
    Chong D; Chen Z; Guan S; Zhang T; Xu N; Zhao Y; Li C
    J Genet Genomics; 2021 Apr; 48(4):300-311. PubMed ID: 34049800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geranylgeranyl pyrophosphate amplifies T
    Pandit M; Acharya S; Gu Y; Seo SU; Kweon MN; Kang B; Chang JH
    Eur J Immunol; 2021 Jun; 51(6):1461-1472. PubMed ID: 33548071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
    Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M
    Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells.
    Alizadeh J; Zeki AA; Mirzaei N; Tewary S; Rezaei Moghadam A; Glogowska A; Nagakannan P; Eftekharpour E; Wiechec E; Gordon JW; Xu FY; Field JT; Yoneda KY; Kenyon NJ; Hashemi M; Hatch GM; Hombach-Klonisch S; Klonisch T; Ghavami S
    Sci Rep; 2017 Mar; 7():44841. PubMed ID: 28344327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitor simvastatin overcomes bortezomib-induced apoptosis resistance by disrupting a geranylgeranyl pyrophosphate-dependent survival pathway.
    Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C
    Biochem Biophys Res Commun; 2008 Sep; 374(2):309-14. PubMed ID: 18625202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation.
    Weivoda MM; Hohl RJ
    Endocrinology; 2011 Aug; 152(8):3113-22. PubMed ID: 21586555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin suppresses leptin expression in 3T3-L1 adipocytes via activation of the cyclic AMP-PKA pathway induced by inhibition of protein prenylation.
    Maeda T; Horiuchi N
    J Biochem; 2009 Jun; 145(6):771-81. PubMed ID: 19254925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of cholesterol, farnesylpyrophosphate, and geranylgeranylpyrophosphate in neuroblastoma SH-SY5Y-APP695 cells: impact on amyloid beta-protein production.
    Hooff GP; Peters I; Wood WG; Müller WE; Eckert GP
    Mol Neurobiol; 2010 Jun; 41(2-3):341-50. PubMed ID: 20405344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 polyisoprenoid diphosphate phosphatase modulates geranylgeranyl-mediated control of HMG CoA reductase and UBIAD1.
    Elsabrouty R; Jo Y; Hwang S; Jun DJ; DeBose-Boyd RA
    Elife; 2021 Nov; 10():. PubMed ID: 34842525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyb5r3 links FoxO1-dependent mitochondrial dysfunction with β-cell failure.
    Fan J; Du W; Kim-Muller JY; Son J; Kuo T; Larrea D; Garcia C; Kitamoto T; Kraakman MJ; Owusu-Ansah E; Cirulli V; Accili D
    Mol Metab; 2020 Apr; 34():97-111. PubMed ID: 32180563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin exerts anticancer effects in osteosarcoma cell lines via geranylgeranylation and c-Jun activation.
    Kany S; Woschek M; Kneip N; Sturm R; Kalbitz M; Hanschen M; Relja B
    Int J Oncol; 2018 Apr; 52(4):1285-1294. PubMed ID: 29532878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.